Expression of S100A2 and S100A6 in thyroid carcinomas

Histopathology

Volumn 46, Issue 5, 2005, Pages 569-575

  Ito, Yasuhiro ^a   Yoshida, H ^a   Tomoda, C ^a   Uruno, T ^a   Miya, A ^a   Kobayashi, K ^a   Matsuzuka, F ^a   Kakudo, K ^a   Kuma, K ^b   Miyauchi, A ^a  

^a KUMA HOSPITAL   (Japan)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Immunohistochemistry; S100A2; S100A6; Thyroid carcinoma

Indexed keywords

CALCIUM BINDING PROTEIN; CALCYCLIN; PROTEIN S 100; PROTEIN S100A2; UNCLASSIFIED DRUG;

ANAPLASTIC CARCINOMA; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID ADENOMA; THYROID CARCINOMA; THYROID FOLLICLE; THYROID FOLLICULAR CARCINOMA; TUMOR GROWTH;

ADENOCARCINOMA, FOLLICULAR; CARCINOMA, PAPILLARY; CELL CYCLE PROTEINS; CHEMOTACTIC FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; S100 PROTEINS; THYROID NEOPLASMS;

EID: 20944441516     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2005.02137.x     Document Type: Article

References (28)

1. LiVolsi VA, Asa SL. The demise of follicular carcinoma of the thyroid gland. Thyroid 1994; 4; 233-237.
2. Aldinger KA, Samaan NA, Ibanez M, Hill CS Jr. Anaplastic carcinoma of the thyroid: a review of 84 cases of spindle and giant-cell carcinoma of the thyroid. Cancer 1978; 41; 2267-2275.
3. Ito Y, Yoshida H, Tomoda C et al. S100A4 expresssion is an early event of papillary carcinoma of the thyroid. Oncology 2004; 67; 397-402.
4. Tan M, Heizmann CW, Guan K. Transcriptional activation of the human S100A2 protein by wild-type p53. FEBS Lett. 1999; 445; 265-268.
5. Wicki R, Franz C, Scholl FA, Heizmann CW, Schafer BW. Repression of the candidate tumor suppressor gene S100A2 in breast cancer is mediated by site-specific hypermethylation. Cell Calcium 1997; 22; 243-254.
6. Stradal TB, Troxler H, Heizmann CW, Gimona M. Mapping the zinc ligands of S100A2 by site directed mutagenesis. J. Biol. Chem. 2000; 275; 13219-13227.
7. Lee SW, Tomasetto C, Swisshelm K, Keyomarsi K, Sager R. Down-regulation of a member of the S100 gene family in mammary carcinoma cells and re-expression by azadeoxycytidine treatment. Proc. Natl Acad. Sci. USA 1992; 89; 2504-2508.
8. Pedrocchi M, Schafer BW, Muller H, Eppenberger U, Heizmann CW. Expression of Ca2+-binding proteins of the S100A2 family in malignant human breast-cancer cell lines and biopsy samples. Int. J. Cancer 1994; 57; 684-690.
9. Lauriola L, Michetti F, Maggiano N et al. Prognostic significance of the Ca2+ binding protein S100A2 in laryngeal squamous-cell carcinoma. Int. J. Cancer 2000; 89; 345-349.
10. Gupta S, Hussain T, Maclennan GT, Fu P, Patel J, Mukhtar H. Differential expression of S100A2 and S100A4 during progression of human prostate adenocarcinoma. J. Clin. Oncol. 2003; 21; 106-112.
11. Kyriazanos ID, Tachibana M, Dhar DK et al. Expression and prognostic significance of S100A2 protein in squamous cell carcinoma of the esophagus. Oncol. Rep. 2002; 9; 503-510.
12. Calabretta B, Battinin R, Kaczmarek L, de Riel JK, Baserga R. Molecular cloning of the cDNA for a growth factor-inducible gene with strong homology to S-100, a calcium-binding protein. J. Biol. Chem. 1986; 261; 12628-12632.
13. Jackson-Grusby LL, Swiergiel J, Linzer DIH. A growth-related mRNA in cultured mouse cells encodes a placental calcium binding protein. Nucl Acids Res. 1987; 15; 6677-6690.
14. Tonini GP, Casalaro A, Cara A, Di Martino D. Inducible expression of calcyclin, a gene with strong homology to S-100 protein, during neuroblastoma cell differentiation and its prevalent expression in Schwann-like cell lines. Cancer Res. 1991; 51; 1733-1737.
15. Biesiada E, Chorazy M. Expression of 'cell-cycle-dependent' genes in regenerating rat liver. Cell Biol. Int. Rep. 1988; 12; 483-492.
16. Timmons PM, Chan CTJ, Rigby PWJ, Poirier F. The gene encoding the calcium binding protein calcyclin is expressed at sites of exocytosis in the mouse. J. Cell Sci. 1993; 104; 187-196.
17. Okazaki K, Niki I, Iino S, Kobayashi S, Hidaka H. A role of calcyclin, a Ca2+-binding protein, on the Ca2+-dependent insulin release from the pancreatic beta cell. J. Biol. Chem. 1994; 269; 6149-6152.
18. Guo X, Chambers AF, Parfett CLJ et al. Identification of a serum-inducible messenger RNA (5B10) as the mouse homologue of calcyclin: tissue distribution and expression in metastatic, ras-transformed NIH 3T3 cells. Cell Growth Differ. 1990; 1; 333-338.
19. Weterman MAJ, Stoopen GM, van Muijen GNP, Kuznicki J, Ruiter DJ, Bloemers HPJ. Expression of calcyclin in human melanoma cell lines correlates with metastatic behavior in nude mice. Cancer Res. 1992; 52; 1291-1296.
20. Weterman MAJ, van Muijen GNP, Bloemers HPJ, Ruiter DJ. Expression of calcyclin in human melanocytic lesions. Cancer Res. 1993; 53; 6061-6066.
21. Ug EC, Schafer BW, Heizmann CW. Expression pattern of S100 calcium-binding proteins in human tumors. Int. J. Cancer 1996; 68; 325-332.
22. Ribe A, McNutt S. S100A6 protein expression is different in Spits nevi and melanomas. Mod. Pathol 2003; 16; 505-511.
23. Boni R., Heizmann CW, Doguoglu A et al. Ca2+-binding proteins S100A6 and S100B in primary cutaneous melanoma. J. Cutan. Pathol. 1997; 24; 76-80.
24. Cmogorac-Jurcevic T, Missiaglia E, Blaveri E et al. Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent. J. Pathol. 2003; 201; 63-74.
25. Stulik J, Osterreicher J, Koupilova K et al. Differential expression of the Ca2+ binding S100A6 protein in normal, preneoplastic and neoplastic colon mucosa. Eur. J. Cancer 2000; 36; 1050-1059.
26. Komatsu K, Murata K, Kameyama M et al. Expression of S100A6 and S100A4 in matched samples of human colorectal mucosa, primary colorectal adenocarcinoma and liver metastases. Oncology 2002; 63; 192-200.
27. Bronckart Y, Decaestecker C, Nagy N et al. Development and progression of malignancy in human colon tissues are correlated with expression of specific Ca2+-binding S100 proteins. Histol. Histopathol 2001; 16; 707-712.
28. Ito Y, Uruno R, Nakano K et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 2003; 13; 381-388.